CoChat
Sign Up
Cited by 72

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes

Fong, Lauren K., Yang, Max M., dos Santos Chaves, Rodrigo, Reyna, Sol M., Langness, Vanessa F., Woodruff, Grace, Roberts, Elizabeth A., Young, Jessica E., Goldstein, Lawrence S.B.·2018·Journal of Biological Chemistry
DOI 10.1074/jbc.ra117.000441
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.ra117.000441

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 58

  1. Hardy, 1997, Amyloid, the presenilins and Alzheimer's disease, Trends Neurosci, 20, 154, 10.1016/S0166-2236(96)01030-2 · DOI · Paper page
  2. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  3. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  4. Liu, 2013, Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy, Nat. Rev. Neurol, 9, 106, 10.1038/nrneurol.2012.263 · DOI · Paper page
  5. Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI
  6. Yaffe, 2002, Serum lipoprotein levels, statin use, and cognitive function in older women, Arch. Neurol, 59, 378, 10.1001/archneur.59.3.378 · DOI
  7. Rockwood, 2002, Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people, Arch. Neurol, 59, 223, 10.1001/archneur.59.2.223 · DOI
  8. van der Kant, 2015, Cellular functions of the amyloid precursor protein from development to dementia, Dev. Cell, 32, 502, 10.1016/j.devcel.2015.01.022 · DOI
  9. Grimm, 2005, Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin, Nat. Cell Biol, 7, 1118, 10.1038/ncb1313 · DOI
  10. Liu, 2007, Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1, Neuron, 56, 66, 10.1016/j.neuron.2007.08.008 · DOI · Paper page
  11. Tamboli, 2008, Loss of γ-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis, J. Neurosci, 28, 12097, 10.1523/JNEUROSCI.2635-08.2008 · DOI · Paper page
  12. Pierrot, 2013, Amyloid precursor protein controls cholesterol turnover needed for neuronal activity, EMBO Mol. Med, 5, 608, 10.1002/emmm.201202215 · DOI
  13. Wang, 2014, Amyloid precursor protein α- and β-cleaved ectodomains exert opposing control of cholesterol homeostasis via SREBP2, FASEB J, 28, 849, 10.1096/fj.13-239301 · DOI
  14. Goldstein, 2006, Protein sensors for membrane sterols, Cell, 124, 35, 10.1016/j.cell.2005.12.022 · DOI · Paper page
  15. Deane, 2004, LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms, Neuron, 43, 333, 10.1016/j.neuron.2004.07.017 · DOI · Paper page
  16. Basak, 2012, Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes, J. Biol. Chem, 287, 13959, 10.1074/jbc.M111.288746 · DOI · Paper page
  17. Nicolas, 2014, Amyloid precursor protein and neural development, Development, 141, 2543, 10.1242/dev.108712 · DOI
  18. Yuan, 2011, Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells, PLoS ONE, 6, e17540, 10.1371/journal.pone.0017540 · DOI
  19. Björkhem, 2004, Brain cholesterol: long secret life behind a barrier, Arterioscler. Thromb. Vasc. Biol, 24, 806, 10.1161/01.ATV.0000120374.59826.1b · DOI · Paper page
  20. Nieweg, 2009, Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats, J. Neurochem, 109, 125, 10.1111/j.1471-4159.2009.05917.x · DOI · Paper page
  21. Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, 89, 331, 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  22. Yang, 2006, Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands, J. Biol. Chem, 281, 27816, 10.1074/jbc.M603781200 · DOI
  23. Zhang, 2016, Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse, Neuron, 89, 37, 10.1016/j.neuron.2015.11.013 · DOI · Paper page
  24. Llorente-Cortés, 2006, Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription, J. Mol. Biol, 359, 950, 10.1016/j.jmb.2006.04.008 · DOI
  25. van Dam, 2002, Endocytosed transferrin receptors recycle via distinct dynamin and phosphatidylinositol 3-kinase-dependent pathways, J. Biol. Chem, 277, 48876, 10.1074/jbc.M206271200 · DOI
  26. Woodruff, 2016, Defective transcytosis of APP and lipoproteins in human iPSC-derived neurons with familial Alzheimer's disease mutations, Cell Rep, 17, 759, 10.1016/j.celrep.2016.09.034 · DOI · Paper page
  27. Tamaoka, 1994, APP717 missense mutation affects the ratio of amyloid β protein species (Aβ 1–42/43 and Aβ 1–40) in familial Alzheimer's disease brain, J. Biol. Chem, 269, 32721, 10.1016/S0021-9258(20)30050-8 · DOI
  28. Suzuki, 1994, An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants, Science, 264, 1336, 10.1126/science.8191290 · DOI · Paper page
  29. Chen, 2008, Assessing the sensitivity of commercially available fluorophores to the intracellular environment, Anal. Chem, 80, 7437, 10.1021/ac8011347 · DOI
  30. Vassar, 1999, β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735 · DOI · Paper page
  31. Choy, 2012, Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network, Proc. Natl. Acad. Sci. U.S.A, 109, E2077, 10.1073/pnas.1208635109 · DOI
  32. Yamakawa, 2010, β-Secretase inhibitor potency is decreased by aberrant β-cleavage location of the “Swedish Mutant” amyloid precursor protein, J. Biol. Chem, 285, 1634, 10.1074/jbc.M109.066753 · DOI
  33. Kounnas, 1995, LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation, Cell, 82, 331, 10.1016/0092-8674(95)90320-8 · DOI · Paper page
  34. Knauer, 1996, Cell surface APP751 forms complexes with protease nexin 2 ligands is internalized via the low density lipoprotein receptor-related protein (LRP), Brain Res, 740, 6, 10.1016/S0006-8993(96)00711-1 · DOI
  35. Pietrzik, 2004, FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein, J. Neurosci, 24, 4259, 10.1523/JNEUROSCI.5451-03.2004 · DOI · Paper page
  36. Trommsdorff, 1998, Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein, J. Biol. Chem, 273, 33556, 10.1074/jbc.273.50.33556 · DOI · Paper page
  37. Bu, 2006, LRP in amyloid-β production and metabolism, Ann. N.Y. Acad. Sci, 1086, 35, 10.1196/annals.1377.005 · DOI
  38. Hass, 1998, Physical interaction of ApoE with amyloid precursor protein independent of the amyloid Aβ region in vitro, J. Biol. Chem, 273, 13892, 10.1016/S0021-9258(19)57838-3 · DOI
  39. Kamal, 2000, Axonal transport of amyloid precursor protein is mediated by direct binding to the Kinesin light chain subunit of kinesin-I, Neuron, 28, 449, 10.1016/S0896-6273(00)00124-0 · DOI · Paper page
  40. Schmidt, 2007, SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1, J. Biol. Chem, 282, 32956, 10.1074/jbc.M705073200 · DOI · Paper page
  41. Barrett, 2012, The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol, Science, 336, 1168, 10.1126/science.1219988 · DOI · Paper page
  42. McDonald, 2012, A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma, J. Lipid Res, 53, 1399, 10.1194/jlr.D022285 · DOI
  43. Mauch, 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science, 294, 1354, 10.1126/science.294.5545.1354 · DOI · Paper page
  44. Karch, 2014, Alzheimer's disease genetics: from the bench to the clinic, Neuron, 83, 11, 10.1016/j.neuron.2014.05.041 · DOI · Paper page
  45. Ryan, 2016, Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series, Lancet Neurol, 15, 1326, 10.1016/S1474-4422(16)30193-4 · DOI
  46. Hsiao, 1996, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  47. Mucke, 2000, High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci, 20, 4050, 10.1523/JNEUROSCI.20-11-04050.2000 · DOI · Paper page
  48. Oddo, 2003, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction, Neuron, 39, 409, 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
  49. Siman, 1989, Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage, Neuron, 3, 275, 10.1016/0896-6273(89)90252-3 · DOI
  50. Töpper, 1995, Rapid appearance of β-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury, Acta Neuropathol, 89, 23, 10.1007/BF00294255 · DOI
  51. Almenar-Queralt, 2014, UV irradiation accelerates amyloid precursor protein (APP) processing and disrupts APP axonal transport, J. Neurosci, 34, 3320, 10.1523/JNEUROSCI.1503-13.2014 · DOI
  52. Ulery, 2000, Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease, J. Biol. Chem, 275, 7410, 10.1074/jbc.275.10.7410 · DOI · Paper page
  53. Marzolo, 2009, Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease, Semin. Cell Dev. Biol, 20, 191, 10.1016/j.semcdb.2008.10.005 · DOI · Paper page
  54. Woodruff, 2013, The presenilin-1 dE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells, Cell Rep, 5, 974, 10.1016/j.celrep.2013.10.018 · DOI · Paper page
  55. Young, 2015, Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells, Cell Stem Cell, 16, 373, 10.1016/j.stem.2015.02.004 · DOI
  56. Mali, 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823, 10.1126/science.1232033 · DOI · Paper page
  57. Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nat. Protoc, 8, 2281, 10.1038/nprot.2013.143 · DOI · Paper page
  58. D'Antonio, 2017, High-throughput and cost-effective characterization of induced pluripotent stem cells, Stem Cell Reports, 8, 1101, 10.1016/j.stemcr.2017.03.011 · DOI

Cited by

Sorted by citations

Metadata

Authors
Fong, L. K., Yang, M. M., dos Santos Chaves, R., Reyna, S. M., Langness, V. F., Woodruff, G., Roberts, E. A., Young, J. E., & Goldstein, L. S. B.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2018-07
Volume
293
Issue
29
Pages
11341-11357
ISSN
0021-9258
DOI
10.1074/jbc.ra117.000441
Cited by
72
References
20
Language
en
Licence
Funders
  • HHS National Institutes of Health (NIH) (T32 GM008666)
  • HHS NIH National Institute on Aging (NIA) (RF1 AG048083–01, 2P50 AG005131–31)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (2013/18028–9)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review